Search in:

Clinical Ophthalmology Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

141

Views

CrossRef citations to date

Altmetric

Review

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis

DeGaulle I ChigbuPennsylvania College of Optometry Salus University, Elkins Park, PA, USACorrespondence[email protected]

Alissa M CoynePennsylvania College of Optometry Salus University, Elkins Park, PA, USA

Pages 1215-1225 | Published online: 08 Jul 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Akila KDr.Dr., Sriya SridharDr.Dr., Swetha SridharDr.Dr. & C.R. JayanthiDr.Dr.. (2022) “A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ALCAFTADINE 0.25% VERSUS OLOPATADINE HYDROCHLORIDE 0.2% IN ALLERGIC CONJUNCTIVITIS AT A TERTIARY CARE HOSPITAL”. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 34-37.
Crossref

Bisant A. Labib & DeGaulle I. Chigbu. (2022) Therapeutic Targets in Allergic Conjunctivitis. Pharmaceuticals 15:5, pages 547.
Crossref

Shruti Ayyappanavar, Sriya Sridhar, Kiran Kumar, CR Jayanthi, SureshBabu Gangasagara, BL Sujatha Rathod, B Preethi & Preeti Mittal. (2021) Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis. Indian Journal of Ophthalmology 69:2, pages 257.
Crossref

Sarah E. Kenny, Cooper B. Tye, Daniel A. Johnson & Ahmad Kheirkhah. (2020) Giant papillary conjunctivitis: A review. The Ocular Surface 18:3, pages 396-402.
Crossref

Pakhuri Mehta, Przemysław Miszta, Przemysław Rzodkiewicz, Olga Michalak, Piotr Krzeczyński & Sławomir Filipek. (2020) Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases. Life 10:4, pages 50.
Crossref

David W. Shirley, James Sterrett, Neal Haga & Catherine Durham. (2020) The therapeutic versatility of antihistamines. The Nurse Practitioner 45:2, pages 8-21.
Crossref

DeGaulle I. Chigbu, Pooja Jain & Zafar K. Khan. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control 229 277 .

Sung Il Kim, Choul Yong Park, Gladys Fordjuor, Jong Heon Lee, Jong Soo Lee & Ji Eun Lee. (2019) Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents. BMC Ophthalmology 19:1.
Crossref

Jae Hyuk Kim, Hyun Joon Kim & Sun Woong Kim. (2019) Allergic contact dermatitis of both eyes caused by alcaftadine 0.25%: a case report. BMC Ophthalmology 19:1.
Crossref

Xuegu Xu & Yonghao Cai. (2018) Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis. Experimental and Therapeutic Medicine.
Crossref

Hadas Ben-Eli & Abraham Solomon. (2018) Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends. Current Opinion in Allergy & Clinical Immunology 18:5, pages 411-416.
Crossref

DeGaulle I. Chigbu & Bhawanjot K. Minhas. (2018) Immunopathology of Allergic Conjunctivitis. European Medical Journal, pages 76-83.
Crossref

Hyungbin Hwang. (2017) Pathogenesis of allergic conjunctivitis and trends in its treatment. Journal of the Korean Medical Association 60:3, pages 251.
Crossref

Jong Soo LeeJong Moon ParkHyun Kyung ChoSu Jin KimHyoun Do HuhYoung Min Park. (2017) Ocular Side Effects Induced by 0.25% Alcaftadine Ophthalmic Solution. Journal of the Korean Ophthalmological Society 58:5, pages 595.
Crossref

Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery 223 239 .

Marcus Shaker & Erin Salcone. (2016) An update on ocular allergy. Current Opinion in Allergy & Clinical Immunology 16:5, pages 505-510.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date